nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.148	0.221	CbGbCtD
Phenylbutazone—PTGS2—Etoposide—uterine cancer	0.129	0.193	CbGbCtD
Phenylbutazone—PTGS1—Etoposide—uterine cancer	0.109	0.163	CbGbCtD
Phenylbutazone—CYP2C9—Progesterone—uterine cancer	0.0979	0.146	CbGbCtD
Phenylbutazone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.086	0.128	CbGbCtD
Phenylbutazone—CYP3A4—Progesterone—uterine cancer	0.0569	0.0851	CbGbCtD
Phenylbutazone—CYP3A4—Etoposide—uterine cancer	0.0255	0.0381	CbGbCtD
Phenylbutazone—PTGIS—artery—uterine cancer	0.0237	0.164	CbGeAlD
Phenylbutazone—CYP3A4—Doxorubicin—uterine cancer	0.0174	0.026	CbGbCtD
Phenylbutazone—PTGIS—myometrium—uterine cancer	0.0114	0.0792	CbGeAlD
Phenylbutazone—PTGIS—smooth muscle tissue—uterine cancer	0.00864	0.0599	CbGeAlD
Phenylbutazone—PTGIS—decidua—uterine cancer	0.00847	0.0587	CbGeAlD
Phenylbutazone—PTGIS—mammalian vulva—uterine cancer	0.00778	0.0539	CbGeAlD
Phenylbutazone—PTGIS—uterus—uterine cancer	0.00741	0.0513	CbGeAlD
Phenylbutazone—PTGS1—oviduct—uterine cancer	0.00669	0.0464	CbGeAlD
Phenylbutazone—PTGIS—female reproductive system—uterine cancer	0.00666	0.0462	CbGeAlD
Phenylbutazone—PTGIS—female gonad—uterine cancer	0.00606	0.042	CbGeAlD
Phenylbutazone—SLC22A11—renal system—uterine cancer	0.00466	0.0323	CbGeAlD
Phenylbutazone—PTGS1—artery—uterine cancer	0.00443	0.0307	CbGeAlD
Phenylbutazone—PTGS2—artery—uterine cancer	0.00424	0.0294	CbGeAlD
Phenylbutazone—PTGIS—lymph node—uterine cancer	0.0039	0.027	CbGeAlD
Phenylbutazone—SLC22A11—female reproductive system—uterine cancer	0.00373	0.0258	CbGeAlD
Phenylbutazone—SLC22A8—renal system—uterine cancer	0.00263	0.0182	CbGeAlD
Phenylbutazone—PTGS2—myometrium—uterine cancer	0.00205	0.0142	CbGeAlD
Phenylbutazone—PTGS1—epithelium—uterine cancer	0.00168	0.0116	CbGeAlD
Phenylbutazone—PTGS1—uterine cervix—uterine cancer	0.00167	0.0115	CbGeAlD
Phenylbutazone—PTGS1—smooth muscle tissue—uterine cancer	0.00162	0.0112	CbGeAlD
Phenylbutazone—PTGS2—epithelium—uterine cancer	0.00161	0.0111	CbGeAlD
Phenylbutazone—PTGS2—uterine cervix—uterine cancer	0.00159	0.011	CbGeAlD
Phenylbutazone—PTGS1—renal system—uterine cancer	0.00156	0.0108	CbGeAlD
Phenylbutazone—PTGS2—smooth muscle tissue—uterine cancer	0.00155	0.0107	CbGeAlD
Phenylbutazone—PTGS1—endometrium—uterine cancer	0.00151	0.0104	CbGeAlD
Phenylbutazone—PTGS2—renal system—uterine cancer	0.00149	0.0103	CbGeAlD
Phenylbutazone—PTGS1—mammalian vulva—uterine cancer	0.00146	0.0101	CbGeAlD
Phenylbutazone—PTGS2—endometrium—uterine cancer	0.00144	0.00998	CbGeAlD
Phenylbutazone—PTGS1—uterus—uterine cancer	0.00139	0.00962	CbGeAlD
Phenylbutazone—CYP2C9—female reproductive system—uterine cancer	0.00137	0.00947	CbGeAlD
Phenylbutazone—PTGS2—uterus—uterine cancer	0.00133	0.0092	CbGeAlD
Phenylbutazone—CYP3A4—renal system—uterine cancer	0.0013	0.00902	CbGeAlD
Phenylbutazone—PTGS1—female reproductive system—uterine cancer	0.00125	0.00865	CbGeAlD
Phenylbutazone—PTGS2—female reproductive system—uterine cancer	0.00119	0.00827	CbGeAlD
Phenylbutazone—PTGS1—female gonad—uterine cancer	0.00114	0.00787	CbGeAlD
Phenylbutazone—PTGS1—vagina—uterine cancer	0.00113	0.00782	CbGeAlD
Phenylbutazone—PTGS2—female gonad—uterine cancer	0.00109	0.00752	CbGeAlD
Phenylbutazone—PTGS2—vagina—uterine cancer	0.00108	0.00748	CbGeAlD
Phenylbutazone—CYP3A4—female reproductive system—uterine cancer	0.00104	0.00722	CbGeAlD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—GPX3—uterine cancer	0.000745	0.004	CbGpPWpGaD
Phenylbutazone—PTGS1—lymph node—uterine cancer	0.00073	0.00506	CbGeAlD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000721	0.00387	CbGpPWpGaD
Phenylbutazone—PTGS2—lymph node—uterine cancer	0.000698	0.00484	CbGeAlD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CXCL8—uterine cancer	0.000641	0.00344	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00062	0.00333	CbGpPWpGaD
Phenylbutazone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—uterine cancer	0.000597	0.0032	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—GPX3—uterine cancer	0.000592	0.00318	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—uterine cancer	0.000564	0.00303	CbGpPWpGaD
Phenylbutazone—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000561	0.00301	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.00054	0.0029	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—SRD5A2—uterine cancer	0.000521	0.00279	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—NDUFB11—uterine cancer	0.000521	0.00279	CbGpPWpGaD
Phenylbutazone—PTGS2—S1P1 pathway—VEGFA—uterine cancer	0.00052	0.00279	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—CTNNB1—uterine cancer	0.00052	0.00279	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000506	0.00271	CbGpPWpGaD
Phenylbutazone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000494	0.00265	CbGpPWpGaD
Phenylbutazone—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000488	0.00262	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKR1B10—uterine cancer	0.000484	0.0026	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00048	0.00257	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000478	0.00256	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000454	0.00243	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—CYP11A1—uterine cancer	0.000405	0.00217	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000403	0.00216	CbGpPWpGaD
Phenylbutazone—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000401	0.00215	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—RNF43—uterine cancer	0.000401	0.00215	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000383	0.00205	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—AKR1B10—uterine cancer	0.000377	0.00203	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKR1B1—uterine cancer	0.000376	0.00202	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—STAR—uterine cancer	0.000376	0.00202	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000372	0.002	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000366	0.00196	CbGpPWpGaD
Phenylbutazone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000364	0.00195	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000359	0.00193	CbGpPWpGaD
Phenylbutazone—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000359	0.00193	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	0.000351	0.00188	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKR1C1—uterine cancer	0.00033	0.00177	CbGpPWpGaD
Phenylbutazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000326	0.00175	CbGpPWpGaD
Phenylbutazone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000322	0.00173	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.000308	0.00165	CbGpPWpGaD
Phenylbutazone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	0.000307	0.00165	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000305	0.00164	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000304	0.00163	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—CCL2—uterine cancer	0.000299	0.00161	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—CYP19A1—uterine cancer	0.000298	0.0016	CbGpPWpGaD
Phenylbutazone—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000297	0.00159	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—POLD1—uterine cancer	0.000295	0.00159	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—uterine cancer	0.000295	0.00159	CbGpPWpGaD
Phenylbutazone—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000295	0.00158	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—DCN—uterine cancer	0.000285	0.00153	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000285	0.00153	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKR1C1—uterine cancer	0.000276	0.00148	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	0.000271	0.00145	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000264	0.00142	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00026	0.00139	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00026	0.00139	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000258	0.00139	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	0.000257	0.00138	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	0.000256	0.00138	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKR1C3—uterine cancer	0.000254	0.00136	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	0.000253	0.00136	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000249	0.00134	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HMGA1—uterine cancer	0.000248	0.00133	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—RRM2—uterine cancer	0.000246	0.00132	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	0.000241	0.00129	CbGpPWpGaD
Phenylbutazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.00024	0.00129	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000239	0.00129	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—DCN—uterine cancer	0.000239	0.00128	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—CCL2—uterine cancer	0.000238	0.00128	CbGpPWpGaD
Phenylbutazone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000237	0.00127	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000231	0.00124	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—FBXW7—uterine cancer	0.000226	0.00122	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	0.000226	0.00121	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CYP11A1—uterine cancer	0.000225	0.00121	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	0.000218	0.00117	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000217	0.00117	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CDKN2A—uterine cancer	0.000215	0.00115	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	0.000213	0.00114	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKR1C3—uterine cancer	0.000213	0.00114	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	0.00021	0.00113	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000206	0.00111	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000206	0.00111	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	0.000198	0.00106	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000195	0.00105	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000194	0.00104	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000191	0.00102	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CDKN1B—uterine cancer	0.00019	0.00102	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000189	0.00101	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CCL2—uterine cancer	0.000188	0.00101	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	0.000185	0.000995	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CDKN2B—uterine cancer	0.000177	0.000952	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.00017	0.000911	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	0.000167	0.000898	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—STK11—uterine cancer	0.000166	0.000889	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CYP19A1—uterine cancer	0.000166	0.000889	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SMAD3—uterine cancer	0.000162	0.000869	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NDUFB11—uterine cancer	0.00016	0.000859	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SRD5A2—uterine cancer	0.00016	0.000859	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	0.000157	0.00084	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	0.000156	0.00084	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000156	0.000835	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000155	0.000834	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—FGFR2—uterine cancer	0.000154	0.000829	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	0.000154	0.000829	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000151	0.000813	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000149	0.0008	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MTHFR—uterine cancer	0.000149	0.000798	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	0.000149	0.000798	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000148	0.000796	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000147	0.000788	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000145	0.000779	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	0.000145	0.000779	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.00014	0.000753	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000138	0.000743	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000137	0.000733	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000137	0.000733	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	0.000135	0.000723	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	0.000131	0.000702	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NDUFB11—uterine cancer	0.000127	0.000682	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SRD5A2—uterine cancer	0.000127	0.000682	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—MTHFR—uterine cancer	0.000125	0.000668	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000123	0.000662	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKR1B10—uterine cancer	0.000118	0.000633	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000117	0.000626	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—STAR—uterine cancer	0.000116	0.000621	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKR1B1—uterine cancer	0.000116	0.000621	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	0.000114	0.000614	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000114	0.000614	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.00011	0.000589	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000107	0.000572	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	0.000103	0.000554	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	0.000102	0.000547	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.0001	0.000538	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	9.87e-05	0.00053	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RNF43—uterine cancer	9.78e-05	0.000525	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ERBB2—uterine cancer	9.7e-05	0.000521	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	9.33e-05	0.000501	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKR1B1—uterine cancer	9.19e-05	0.000493	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—STAR—uterine cancer	9.19e-05	0.000493	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TP53—uterine cancer	9.12e-05	0.000489	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	9.09e-05	0.000488	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—POLD1—uterine cancer	9.08e-05	0.000487	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	9.08e-05	0.000487	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CDKN1B—uterine cancer	8.98e-05	0.000482	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	8.67e-05	0.000465	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKR1C1—uterine cancer	8.49e-05	0.000456	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CTNNB1—uterine cancer	8.49e-05	0.000456	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NDUFB11—uterine cancer	8.41e-05	0.000452	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SRD5A2—uterine cancer	8.41e-05	0.000452	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTEN—uterine cancer	8.27e-05	0.000444	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	8.21e-05	0.000441	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.17e-05	0.000439	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKR1C1—uterine cancer	8.05e-05	0.000432	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—EP300—uterine cancer	7.89e-05	0.000423	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.72e-05	0.000414	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—RRM2—uterine cancer	7.57e-05	0.000406	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NRAS—uterine cancer	7.38e-05	0.000396	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—DCN—uterine cancer	7.35e-05	0.000394	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—POLD1—uterine cancer	7.21e-05	0.000387	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	6.98e-05	0.000375	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—DCN—uterine cancer	6.97e-05	0.000374	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTEN—uterine cancer	6.93e-05	0.000372	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP11A1—uterine cancer	6.92e-05	0.000372	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKR1C1—uterine cancer	6.74e-05	0.000362	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—EP300—uterine cancer	6.61e-05	0.000355	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKR1C3—uterine cancer	6.54e-05	0.000351	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	6.41e-05	0.000344	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—KRAS—uterine cancer	6.35e-05	0.000341	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	6.2e-05	0.000333	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKR1C3—uterine cancer	6.2e-05	0.000333	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—STAR—uterine cancer	6.08e-05	0.000326	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKR1B1—uterine cancer	6.08e-05	0.000326	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HMGA1—uterine cancer	6.04e-05	0.000324	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.01e-05	0.000323	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—RRM2—uterine cancer	6.01e-05	0.000323	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PIK3CA—uterine cancer	5.84e-05	0.000313	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—DCN—uterine cancer	5.83e-05	0.000313	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SRD5A2—uterine cancer	5.55e-05	0.000298	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NDUFB11—uterine cancer	5.55e-05	0.000298	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FBXW7—uterine cancer	5.52e-05	0.000296	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP11A1—uterine cancer	5.5e-05	0.000295	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HRAS—uterine cancer	5.4e-05	0.00029	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.24e-05	0.000281	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKR1C3—uterine cancer	5.19e-05	0.000279	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP19A1—uterine cancer	5.09e-05	0.000273	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—STK11—uterine cancer	5.09e-05	0.000273	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CA—uterine cancer	4.89e-05	0.000262	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.78e-05	0.000257	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—POLD1—uterine cancer	4.77e-05	0.000256	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT1—uterine cancer	4.77e-05	0.000256	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.56e-05	0.000245	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKR1C1—uterine cancer	4.46e-05	0.00024	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN2B—uterine cancer	4.33e-05	0.000232	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—STK11—uterine cancer	4.04e-05	0.000217	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP19A1—uterine cancer	4.04e-05	0.000217	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—STAR—uterine cancer	4.01e-05	0.000215	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.01e-05	0.000215	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKT1—uterine cancer	3.99e-05	0.000214	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—RRM2—uterine cancer	3.98e-05	0.000214	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SMAD3—uterine cancer	3.95e-05	0.000212	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—DCN—uterine cancer	3.86e-05	0.000207	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—MTHFR—uterine cancer	3.83e-05	0.000205	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.8e-05	0.000204	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGFR2—uterine cancer	3.77e-05	0.000202	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP11A1—uterine cancer	3.64e-05	0.000195	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTHFR—uterine cancer	3.63e-05	0.000195	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.62e-05	0.000194	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKR1C3—uterine cancer	3.44e-05	0.000184	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.37e-05	0.000181	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—POLD1—uterine cancer	3.15e-05	0.000169	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MTHFR—uterine cancer	3.04e-05	0.000163	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.94e-05	0.000158	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—STK11—uterine cancer	2.68e-05	0.000144	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP19A1—uterine cancer	2.68e-05	0.000144	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.68e-05	0.000144	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—RRM2—uterine cancer	2.62e-05	0.000141	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—DCN—uterine cancer	2.55e-05	0.000137	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.51e-05	0.000135	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.4e-05	0.000129	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.4e-05	0.000129	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ERBB2—uterine cancer	2.37e-05	0.000127	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.27e-05	0.000122	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN1B—uterine cancer	2.19e-05	0.000118	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTEN—uterine cancer	2.13e-05	0.000114	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CTNNB1—uterine cancer	2.07e-05	0.000111	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—EP300—uterine cancer	2.03e-05	0.000109	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PTEN—uterine cancer	2.02e-05	0.000108	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTHFR—uterine cancer	2.01e-05	0.000108	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EP300—uterine cancer	1.93e-05	0.000103	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NRAS—uterine cancer	1.8e-05	9.67e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.77e-05	9.52e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.77e-05	9.48e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—STK11—uterine cancer	1.77e-05	9.48e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PTEN—uterine cancer	1.69e-05	9.07e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—EP300—uterine cancer	1.61e-05	8.65e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KRAS—uterine cancer	1.55e-05	8.32e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CA—uterine cancer	1.5e-05	8.06e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CA—uterine cancer	1.42e-05	7.64e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTHFR—uterine cancer	1.33e-05	7.12e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HRAS—uterine cancer	1.32e-05	7.07e-05	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKT1—uterine cancer	1.23e-05	6.59e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CA—uterine cancer	1.19e-05	6.4e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT1—uterine cancer	1.16e-05	6.24e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTEN—uterine cancer	1.12e-05	6.01e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—EP300—uterine cancer	1.07e-05	5.73e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKT1—uterine cancer	9.74e-06	5.23e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CA—uterine cancer	7.9e-06	4.24e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTEN—uterine cancer	7.38e-06	3.96e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—EP300—uterine cancer	7.04e-06	3.78e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKT1—uterine cancer	6.45e-06	3.46e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CA—uterine cancer	5.21e-06	2.8e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKT1—uterine cancer	4.25e-06	2.28e-05	CbGpPWpGaD
